Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by YEONGHAK BANG
Rivaroxaban Versus Low-Molecular-Weight Heparin for Venous Thromboembolism in Advanced Upper Gastrointestinal Tract and Hepatopancreatobiliary Cancer
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Related publications
Outpatient Use of Low Molecular Weight Heparin Monotherapy for First-Line Treatment of Venous Thromboembolism in Advanced Cancer
Oncologist
Cancer Research
Medicine
Oncology
Low Molecular-Weight Heparin Is Better Than Warfarin for Prevention of Recurrent Venous Thromboembolism in Cancer Patients
Clinical Research in Practice: The Journal of Team Hippocrates
Cost-Effectiveness Analysis of Treatment of Venous Thromboembolism With Rivaroxaban Compared With Combined Low Molecular Weight Heparin/Vitamin K Antagonist
Thrombosis Journal
Hematology
Economic Analysis of Low-Dose Heparin vs the Low-Molecular-Weight Heparin Enoxaparin for Prevention of Venous Thromboembolism After Colorectal Surgery
Archives of Internal Medicine
Low-Molecular-Weight-Heparin Versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in High- And Low-Risk Patients With Active Cancer: A Post Hoc Analysis of the CLOT Study
Journal of Thrombosis and Thrombolysis
Cardiovascular Medicine
Hematology
Cardiology
Low Molecular Weight Heparin
Reactions Weekly
Low Molecular Weight Heparin
Journal of Cardiothoracic and Vascular Anesthesia
Cardiovascular Medicine
Anesthesiology
Pain Medicine
Cardiology
Low Molecular Weight Heparin
Reactions Weekly
Low Molecular Weight Heparin
